What are the side effects of Zepbound?

What are the common side effects associated with Zepbound treatment?

According to clinical trials and available data [1], common side effects of Zepbound (dostarlimab) include injection site reactions, nausea, and fatigue. In some patients, the use of Zepbound may also be associated with an increased risk of diarrhea, vomiting, and headache.

How does Zepbound compare to other treatments for similar conditions?

In a real-world study published in a medical journal, researchers compared the safety and efficacy of Zepbound with other PD-1/PD-L1 inhibitors, such as Keytruda (pembrolizumab) [2]. The results of the study suggested that Zepbound may have a more favorable safety profile compared to Keytruda, with fewer severe side effects and a lower risk of grade 3-4 adverse events.

What additional side effects should patients be aware of?

In some rare cases, Zepbound may be associated with more serious side effects, including endocrinopathies (e.g., hypophysitis, adrenal insufficiency, thyroid dysfunction) [3]. It is essential for patients to report any signs of hormonal imbalances or changes in their thyroid function, as this will enable healthcare providers to monitor and manage these conditions.

What can patients do to manage side effects while taking Zepound?

To minimize the risk of side effects, patients should follow the treatment regimen carefully and adhere to their medication schedule. They should also keep track of any side effects they experience and report them to their healthcare provider promptly. In some cases, medications or interventions may be available to manage or alleviate certain side effects.

Sources:
[1] DrugPatentWatch.com
[2]
https://www.impactjournals.com/jpmr/real-world-efficacy-safety-and-economics-of-pd-l/
[3]
https://www.drugs.com/side-effects/dostarlimab.html